InvestorsHub Logo
Followers 283
Posts 1162
Boards Moderated 0
Alias Born 10/04/2020

Re: rockie101 post# 91441

Wednesday, 09/22/2021 10:04:23 AM

Wednesday, September 22, 2021 10:04:23 AM

Post# of 118366
Good Point!....BUT...

I believe that is about to dramatically change Post 9/28/21 when the OTC will be REDUCED by thousands of Tickers for SEC Non-Compliance!

Of those stocks remaining money will naturally flow into stocks with the lowest risk that have real business operations, funding, partnerships, valuable products or services, a high market demand, revenue or eminently positioned for revenue.

RGBP has ALL the above so IMO that speaks volumes to the Market Demand of this company in particular with it's Disruptive Biotechnology Patents, one of which is mRNA based that's been licensed to Oncology Pharma with (2) INDs for treating pancreatic & colon cancer which is absolutely one of the highest market demand aspects of this company presently.

Just look at the Big Pharma players who are aggressively pursuing mRNA Vaccine development for treating various forms of cancer and the current news that's centered on this market drive:

https://www.ventureradar.com/keyword/Cancer%20Vaccines

https://www.cancernetwork.com/view/messenger-rna-vaccines-beckoning-of-a-new-era-in-cancer-immunotherapy

https://finance.yahoo.com/news/its-game-over-its-m-rna-or-nothing-expert-on-future-of-vaccines-200508222.html

It's absolutely undeniable that RGBP is adequately position in the Market for a substantial rise in it's pps as PR is dropped by the CEO about the company's progress into clinical trials, etc with their mRNA Cancer Vaccine Patents along side the Big Pharma players doing the same thing.